Unisolve

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Unisolve
2.
QUALITATIVE
AND
QUANTITATIVE
COMPOSITION
OF
PRODUCT
ACTIVE INGREDIENT
NOT APPLICABLE
For a full list of excipients please see section 6.1
3.
PHARMACEUTICAL FORM
Clear, colourless, solution consisting of sterile phosphate buffered
saline and
sucrose.
4
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep, cattle, poultry, pigeons and rabbits
4.2
INDICATIONS FOR USE
Diluent for reconstitution of Toxovax, Enzovax, Bovilis IBR, Bovilis
IBR Marker,
Nobilis Marek THV lyo, Nobilis SG 9R.
4.3
CONTRA-INDICATIONS AND WARNINGS IN RESPECT OF OTHER PRODUCTS USED IN
THE
HOST IMMUNOLOGICAL STATUS OF HOST AND PHYSIOLOGICAL STATUS OF HOST
Any contra-indications specified for the vaccine for which the diluent
is used for
reconstitution will apply.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
No special precautions are required for handling the diluent however
any
recommendations specified for the vaccine for which Unisolve is used
as a diluent will
apply.
Special precautions to be taken by the person administering the
product to
animals
None
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Any adverse effects specified for the vaccine for Unisolve is used as
the diluent
will apply.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Unisolve/Legal cat & new SPC (02-08-06)
Any recommendations specified for the vaccine for which Unisolve is
used as the
diluent will apply.
4.8
INTERACTION WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION
None known.
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
The instructions supplied with the vaccine should be read carefully
before using
the diluent.
For freeze dried vaccines the contents of the diluent vial should be
transferred
aseptically into the vial of freeze-dried vaccine immediately prior to
use. In the
case of Toxovax the vaccine concentrate should be added to the diluent
vial in
accordance with the instructions provided.
4.1
                                
                                Read the complete document